AstraZeneca, Daiichi Sankyo partner on cancer ADC

AstraZeneca has entered into an agreement with Daiichi Sankyo to develop and commercialize trastuzumab deruxtecan
Source: PharmaManufacturing.com - Category: Pharmaceuticals Source Type: news